The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tempus AI, Inc. ("Tempus" or ...

Alphabet, UnitedHealth Group, Salesforce, Oracle, ServiceNow, Palo Alto Networks, and Tempus AI are the seven Healthcare ...

In conjunction with its better-than-expected sales growth in the second quarter, Tempus AI raised its sales outlook for this ...

Shares in health technology group Tempus AI ($TEM) raced 7% higher today after its Q2 revenues surged on cancer testing ...

In trading on the Nasdaq stock market as of 1:17 p.m. Central, Tempus' stock price was trading at $60.65, up 3.2% from the ...

Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday. The AI-focused precision medicine and patient ...

The firm's genomics revenues more than doubled year over year, while data and services revenue increased nearly 36 percent.

Tempus AI (NASDAQ:TEM) stock sees a 9% pre-market gain as the company raises its 2025 revenue outlook amid strong Q2 ...

Shares of Tempus AI climbed after the company narrowed its net loss and logged higher-than-expected revenue in the second quarter, boosted by what Chief Executive Eric Lefkofsky called a significant ...

Tempus AI (NASDAQ:TEM) surged 9% in premarket trading on Friday after the genetic testing company posted a ...

CHICAGO (AP) — CHICAGO (AP) — Tempus AI Inc. (TEM) on Friday reported a loss of $42.8 million in its second quarter. The Chicago-based company said it had a loss of 25 cents per share. Losses, ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter ended June 30, 2025.